Skip to main content
. 2024 Aug 9;10(16):e35883. doi: 10.1016/j.heliyon.2024.e35883

Table 1.

Participants’ demographics and clinical characteristics.

YG (n = 16), n (%) CG (n = 18) n (%) t or χ2 p
Age, mean (SD) 48.63 (8.77) [range:37–63] 45.78 (9.25) [range:36–63] t = −0.918 0.366
Education level χ2 = 2.242 0.131
 Primary or below 0 0
 Secondary 4 (25) 9 (50)
 Tertiary 12 (75) 9 (50)
Living status χ2 = 3.702 0.094
 alone 3 (18.8) 0
 family 13 (81.3) 18 (100)
Employment status χ2 = 0.410 0.980
 Full-time 10 (62.5) 11 (61.1)
 Part-time 2 (12.5) 2 (11.1)
 Others (i.e., housewife) 4 (25) 5 (27.8)
Marital status χ2 = 0.283 0.868
 Single 4 (25) 6 (33.3)
 Married 11 (68.8) 11 (61.1)
 Divorced 1 (6.3) 3 (5.6)
 Widowed 0 0
Hand Dominance χ2 = 1.889 0.487
 Right 16 (100) 16 (88.9)
 Left 0 2 (11.1)
Cancer stage χ2 = 0.360 0.835
 I 4 (25) 5 (27.8)
 II 8 (50) 10 (55.6)
 III 4 (25) 3 (16.7)
Duration of cancer diagnosis (months), mean (SD) 18.22 (9.07) [Range: 3.5–44] 22.58 (9.51) [Range: 5–38] t = 1.365 0.182
Post-surgery duration (months), mean (SD) 16.75 (9.44) [Range: 3–43] 22.08 (9.55) [Range: 4.5–37.5] t = 1.634 0.112
Post-chemotherapy/radiotherapy duration (months), mean (SD) 12.72 (9.49) [Range: 2.5–39] 16.75 (10.75) [Range: 2.5–37] t = 1.153 0.258
Surgery-mastectomy χ2 = 0.472 0.732
 Mastectomy 9 (56.3) 8 (44.4)
 Partial mastectomy 7 (43.8) 10 (55.6)
Surgery-lymph node χ2 = 4.386 0.112
 none 1 (6.3) 5 (27.8)
 Sentinel node dissection 7 (43.8) 3 (16.7)
 Lymph node dissection 8 (50) 10 (55.6)
Adjuvant treatments
 Chemotherapy 11 (68.8) 17 (81.3) χ2 = 3.848 0.078
 Radiotherapy 14 (87.5) 13 (72.2) χ2 = 1.209 0.405
 Hormonal therapy 6 (37.5) 6 (33.5) χ2 = 0.064 1.000
Affected side χ2 = 2.902 0.234
 Right 5 (43.8) 9 (50)
 Left 7 (31.3) 8 (44.4)
 Both 4 (25) 1 (5.6)

t, independent-sample t-test; χ2, chi-squared test; YG, yoga intervention group; CG, control group.